← Back to Search

Medication Support Program for Diabetes in Spanish Speakers (DH-Spanish Trial)

N/A

Waitlist Available

Led By Katherine D Vickery, MD

Research Sponsored by Hennepin Healthcare Research Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Self-reported diagnosis of type 2 diabetes, later verified in medical record

Age 18 yrs or older

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at 16 weeks

Awards & highlights

DH-Spanish Trial Summary

This trial tests how feasible and helpful a diabetes medication support program is for Spanish speakers.

Who is the study for?

This trial is for Spanish-speaking adults with type 2 diabetes who have experienced significant housing instability or homelessness. Participants should be willing to improve medication adherence and self-care, plan to stay local or reachable by phone for 16 weeks, and not be pregnant or lactating.Check my eligibility

What is being tested?

The study tests a support program designed specifically for homeless, Spanish-speaking individuals with type 2 diabetes. It aims to understand how participants perceive the program and its feasibility over a single-arm trial involving 12 people.See study design

What are the potential side effects?

Since this trial focuses on a support program rather than a medical intervention, traditional side effects are not applicable. However, participants may experience stress or emotional discomfort when discussing personal health issues.

DH-Spanish Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with type 2 diabetes.

Select...

I am 18 years old or older.

DH-Spanish Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at 16 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at 16 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and at 16 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability of intervention

Secondary outcome measures

Change in glycemic control

Diabetes medication adherence

Health-related quality of life

DH-Spanish Trial Design

1Treatment groups

Experimental Treatment

Group I: DH-Spanish InterventionExperimental Treatment1 Intervention

Behavioral treatment by a diabetes wellness coach.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Hennepin Healthcare Research InstituteLead Sponsor

90 Previous Clinical Trials

77,165 Total Patients Enrolled

National Institutes of Health (NIH)NIH

2,698 Previous Clinical Trials

7,492,487 Total Patients Enrolled

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH

2,359 Previous Clinical Trials

4,315,483 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the scope of participants enrolled in this trial?

"Affirmative. According to the information hosted on clinicaltrials.gov, this medical trial is now recruiting patients and was first posted in April of 2023 with its last edit occuring in May of the same year. This study aims to enrol a total of 12 participants at one site."

Answered by AI

Are there still vacancies for volunteers in this research project?

"Affirmative. According to records on clinicaltrials.gov, this trial is actively accepting participants. Initially posted on April 25th 2023 and most recently edited on May 30th 2023, the study requires 12 volunteers from one site of care."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Diabetes Homelessness Medication Support Program in Spanish

2023. "Diabetes Homelessness Medication Support Program in Spanish". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05819749.